13D/13G Filings - Cytek Biosciences Inc. (CTKB)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
4:09 pm
Purchase
2021-12-31 13G Cytek Biosciences, Inc.
CTKB
HHLR Advisors, Ltd. 8,757,030
6.500%
8,757,030increase
(New Position)
Filing
History
2022-02-14
2:04 pm
Purchase
2021-12-31 13G Cytek Biosciences, Inc.
CTKB
Jiang Wenbin 8,020,483
5.990%
8,020,483increase
(New Position)
Filing
History
2022-02-14
2:01 pm
Purchase
2021-12-31 13G Cytek Biosciences, Inc.
CTKB
Yan Ming 8,203,358
6.130%
8,203,358increase
(New Position)
Filing
History
2021-08-06
4:30 pm
Purchase
2021-07-27 13D Cytek Biosciences, Inc.
CTKB
RA Capital Management, L.P. 9,607,028
7.200%
9,607,028increase
(New Position)
Filing
History
Goto Prev, 0, 1